Form D SPV016 a Series of Engag
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form D/A Albany Street Capital
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form 4 NextDecade Corp For: Sep 09 Filed by: Skeik Tarik
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 485BXT AIM COUNSELOR SERIES
As Filed with the United States
Securities and Exchange Commission on September 11, 2026. 1933 Act
Registration No. 333-36074 1940 Act Registration No. 811-09913
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549
FORM N-1A
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
☒
Pre-Effective Amendment No.
☐
Post-Effective Amendment No. 230
☒ and/or
REGISTRATION... (continue reading...)
Form 6-K Docebo Inc. For: Sep 11
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2026
Commission File Number 001-39750
DOCEBO INC.
(Exact name of Registrant as specified in its charter)
N/A
(Translation of Registrant’s name)
12th Floor – 55 York Street
Toronto, ON, Canada M5J 1R7
(800) 681-4601
More SEC Filings
View Older Stories-
Form 4 NextDecade Corp For: Sep 09 Filed by: de Gyarfas Vera
-
Form 6-K WF International Ltd. For: Sep 11
-
Form 4 NextDecade Corp For: Sep 09 Filed by: Schatzman Matthew K
-
Form 485BXT Tidal Trust V
-
Form 8-K Alcoa Corp For: Sep 10
-
Form D FHA D 2026 a Series of
-
Form D Alerce Medical Co-Invest
-
Form D OTC-MGI-0626 a Series
-
Form 424B5 WF International Ltd.
-
Form 8-K Rent the Runway, Inc. For: Sep 11
-
Form FWP Morgan Stanley Finance Filed by: Morgan Stanley Finance LLC
-
Form 8-K/A Global Net Lease, Inc. For: Aug 12
-
Form FWP MORGAN STANLEY Filed by: MORGAN STANLEY
-
Form 10-Q Rent the Runway, Inc. For: Jul 31
-
Form 10-Q VINCE HOLDING CORP. For: Aug 01
-
Form 8-K Jerash Holdings (US), For: Sep 10
-
Form DEFA14A Columbus Acquisition
-
Form D/A Pantheum Feeder Fund
-
Form 8-K HPS Corporate Lending For: Sep 11
-
Form 8-K Gossamer Bio, Inc. For: Sep 10
-
Form 8-K BlackRock Private Invest For: Sep 11
-
Form 8-K HPS Corporate Capital For: Sep 11
-
Form 8-K Columbus Acquisition For: Sep 10
-
Form 6-K Click Holdings Ltd. For: Sep 11
-
Form 4 Anixa Biosciences Inc For: Sep 10 Filed by: KUMAR AMIT
-
Form 8-K TScan Therapeutics, Inc. For: Sep 08
-
Form 8-K Medicus Pharma Ltd. For: Sep 04
-
Form 8-K BlackRock Private Credit For: Sep 11
-
Form 10-K CXJ GROUP CO., Ltd For: May 31
-
Form 8-K LITHIUM AMERICAS CORP. For: Sep 08
-
Form DEFA14A HeartSciences Inc.
-
Form 8-K Gentherm Inc For: Sep 10
-
Form 6-K Radiopharm Theranostics For: Sep 11
-
Form 8-K Rent the Runway, Inc. For: Sep 11
-
Form 4 StoneX Group Inc. For: Sep 10 Filed by: Lyon Charles M
-
Form D/A TQ Fund LP
-
Form C/A Reiturn Inc.
-
Form D PERSONA AI Feb 2026 a
-
Form 6-K SASOL LTD For: Sep 11
-
Form D/A TQ Offshore Fund Ltd
-
Form 25-NSE ING GROEP NV Filed by: NEW YORK STOCK EXCHANGE LLC
-
Form D PPVP Growth XXV a Series
-
Form D/A Pantheum Feeder Fund LP
-
Form N-CEN 2023 ETF Series Trust For: Jun 30
-
Form D/A TQ Intermediate Fund LP
-
Form 8-K Opus Genetics, Inc. For: Sep 11
-
Form 425 Aperture AC Filed by: Aperture AC
-
Form 8-K Aperture AC For: Sep 10
-
Form D Asylon a Series of Koru
-
Form 8-K Karyopharm Therapeutics For: Sep 10
